AstraZeneca shares jump ~6% after denying merger talks with Bristol-Myers Squibb
AZN Astrazeneca plc
$155.62 -1.49%
차트·분석 보기 → - 1AstraZeneca (AZN) shares surged about 6% on Wednesday after news that there are no merger talks with Bristol-Myers Squibb (BMY).
- 2Senior sources told Reuters that there is no deal or discussions between the two companies, partially reversing a roughly 9% drop on Monday.
- 3A combined deal would have amounted to a market capitalization of roughly $400 billion, but analysts said the strategic rationale was weak.
This 3-line summary is compiled from the report below.
Investing.com +1 View original ↗🎯 오늘의 AI 픽 5종목, 무료로 전부 공개합니다
숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다